The biggest lesson for me is that analyst ratings are opinions, not guarantees.
MSFT’s upgrade shows growing confidence in AI and Azure growth. CoreWeave is more interesting because JPMorgan and Rothschild have very different views: $125 vs $54. This shows how analysts can interpret the same company very differently.
Nike’s downgrade also reminds us that a turnaround can take longer than expected. Meanwhile, Humana’s upgrade shows how improving business expectations can quickly change sentiment.
For investors, I think the most important question is not simply “Buy or Sell?” but “Why did the analyst change the rating?”
I would also avoid making a decision based on one analyst target. It is better to look at earnings, valuation, cash flow, growth and the company's actual results.
💰Stocks to watch today?(24 September）
1. What news/movements are worth noting in the market today? Any stocks to watch?
2. What trading opportunities are there? Do you have any plans?
🎁 Make a post here, everyone stands a chance to win Tiger coins!
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments